FindTrial
Sign In

Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00468026
Enrollment
Unknown
Registered
2007-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2007-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Keywords

BPH, Prostate, Stent, Benign prostatic hyperplasia (BPH)

Brief summary

The purpose of this ex-vivo study is to evaluate the insertion procedure for the ProstaPlant implant in human prostates and the support that it supplies to the prostate.

Interventions

DEVICEProstaPlant Stent

Sponsors

ProstaPlant Urology System Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum

Inclusion criteria

* Males, * 18 years old and up, * Suffer from BPH, * Candidate for radical prostatectomies

Exclusion criteria

* According to the physician's decision

Design outcomes

Primary

MeasureTime frame
This is a feasibility study, in which initial evaluation of stent insertion procedure is obtained—

Countries

Israel

Contacts

Primary ContactJack Baniel, Prof.
972-3-9376563

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026